Browse by Current Cardiff authors

O’Hara, James T., Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Ingarfield, Kate, Patterson, Joanne M., Hutcheson, Katherine, Canham, Joanna E. ORCID: https://orcid.org/0000-0003-3482-0990, Nixon, Lisette S. ORCID: https://orcid.org/0000-0002-1270-6970, Heiberg, Christie D., Johnson, Sean, Evans, Mererid and Jones, Terry M. 2024. Transoral laser or robotic surgery outcomes for oropharyngeal carcinoma. JAMA Otolaryngology-Head and Neck Surgery 150 (11) , pp. 1002-1011. 10.1001/jamaoto.2024.3371

Mukherjee, Somnath, Qi, Cathy, Shaw, Rachel, Jones, Christopher M., Bridgewater, John A., Radhakrishna, Ganesh, Patel, Neel, Holmes, Jane, Virdee, Pradeep S., Tranter, Bethan, Parsons, Philip, Falk, Stephen, Wasan, Harpreet S., Ajithkumar, Thankamma V., Holyoake, Daniel, Roy, Rajarshi, Scott-Brown, Martin, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, O?Neill, Eric, Sebag-Montefiore, David, Maughan, Tim S., Hawkins, Maria A. and Corrie, Pippa 2024. Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial. European Journal of Cancer 209 , 114236. 10.1016/j.ejca.2024.114236 Item availability restricted.

Mukherjee, Somnath, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Bateman, Andrew, Bradley, Kevin M. ORCID: https://orcid.org/0000-0003-1911-3382, Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Falk, Stephen, Griffiths, Gareth, Gwynne, Sarah, Jones, Christopher M., Markham, Philip J. ORCID: https://orcid.org/0000-0002-6119-0157, Maughan, Tim, Nixon, Lisette S. ORCID: https://orcid.org/0000-0002-1270-6970, Radhakrishna, Ganesh, Roy, Rajarshi, Schoenbuchner, Simon, Sheikh, Hamid, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Hawkins, Maria and Crosby, Thomas D.L. 2023. Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial. EClinicalMedicine 61 , 102059. 10.1016/j.eclinm.2023.102059

Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nedjai, Belinda, Alvarez-Mendoza, Carlos, Powell, Ned, Tristram, Amanda and Jones, Sadie 2022. Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia. Cancer Biomarkers 35 , pp. 143-153. 10.3233/CBM-210448

Bridges, S. ORCID: https://orcid.org/0000-0002-7665-5770, Thomas, B., Radhakrishna, G., Hawkins, M., Holborow, A., Hurt, C. ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, S., Nixon, L., Crosby, T. and Gwynne, S. 2022. SCOPE 2 – Still answering the unanswered questions in oesophageal radiotherapy? SCOPE 2: a Randomised phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemoradiation with an embedded phase II trial for patients with a poor early response using positron emission tomography/computed tomography. Clinical Oncology 34 (7) , E269-E280. 10.1016/j.clon.2022.03.019

Brown, Sarah R., Hinsley, Samantha, Hall, Emma, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Baird, Richard D., Forster, Martin, Scarsbrook, Andrew F. and Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243 2022. A road map for designing phase I clinical trials of radiotherapy-novel agent combinations. Clinical Cancer Research 28 (17) , pp. 3639-3651. 10.1158/1078-0432.CCR-21-4087

Bach, Simon P., STAR-TREC Collaborative and Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355 2022. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. Colorectal Disease 24 (5) , pp. 639-651. 10.1111/codi.16056

Shannon, Caitlin, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Soremekun, Seyi, Edmond, Karen, Newton, Sam, Amenga-Etego, Seeba, Tawiah-Agyemang, Charlotte, Hill, Zelee, Manu, Alexander, Weobong, Ben, Kirkwood, Betty and Hurt, Lisa ORCID: https://orcid.org/0000-0002-2741-5383 2022. Implementing effective community-based surveillance in research studies of maternal, newborn and infant outcomes in low resource settings. Emerging Themes in Epidemiology 19 , 1. 10.1186/s12982-021-00109-0

Mukherjee, Somnath, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Radhakrishna, Ganesh, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Hawkins, Maria A., Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Grabsch, Heike I., Falk, Stephen, Sharma, Ricky A., Ray, Ruby, Roy, Rajarshi, Cox, Catrin, Maynard, Nick, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Sebag-Montefiore, David J., Maughan, Timothy, Griffiths, Gareth O. and Crosby, Tom D.L. 2021. Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial. European Journal of Cancer 153 , pp. 153-161. 10.1016/j.ejca.2021.05.020

Byrne, Anthony, Adamson, Douglas, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677 and Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355 2021. Stent insertion for incurable oesophageal carcinoma: what is the optimal treatment? - authors' reply. The Lancet Gastroenterology & Hepatology 6 (7) , 525. 10.1016/S2468-1253(21)00174-6

Jones, Sadie Esme Fleur, Ramirez, Pedro T., Bhandoria, Geetu Prakash, Hsu, Heng-Cheng, Nair, Navya, Noll, Florencia, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Howells, Robert, Lim, Kenneth and Sharma, Aarti 2021. Technique for inguino-femoral lymph node dissection in vulvar cancer: an international survey. International Journal of Gynecological Cancer 31 (6) , pp. 817-823. 10.1136/ijgc-2021-002452

Goulart, Michelle R., Watt, Jennifer, Siddiqui, Imran, Lawlor, Rita T., Imrali, Ahmet, Hughes, Christine, Saad, Amina, ChinAleong, Joanne, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Cox, Catrin, Salvia, Roberto, Mantovani, Alberto, Crnogorac-Jurcevic, Tatjana, Mukherjee, Somnath, Scarpa, Aldo, Allavena, Paola and Kocher, Hemant M. 2021. Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma. npj Precision Oncology 5 (1) , 61. 10.1038/s41698-021-00192-1

Adamson, Douglas, Blazeby, Jane, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Griffiths, Gareth, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Sewell, Bernadette, Jones, Mari, Svobodova, Martina, Fitzsimmons, Deborah, Nixon, Lisette, Fitzgibbon, Jim, Thomas, Stephen, Millin, Anthony, Crosby, Tom, Staffurth, John and Byrne, Anthony 2021. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT. Health Technology Assessment 25 (31) 10.3310/hta25310

Adamson, Douglas, Byrne, Anthony, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Blazeby, Jane, Griffiths, Gareth, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Sewell, Bernadette, Jones, Mari, Svobodova, Martina ORCID: https://orcid.org/0000-0001-7949-4039, Fitzsimmons, Deborah, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Fitzgibbon, Jim, Thomas, Stephen, Millin, Anthony, Crosby, Tom, Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172 and Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355 2021. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial. Lancet Gastroenterology and Hepatology 6 (4) , pp. 292-303. 10.1016/S2468-1253(21)00004-2

Moss, Laura, Cox, Catrin, Wadsley, Jonathan, Newbold, Kate, Strachan, Mark W.J., Druce, Maralyn, Tolley, Neil, Graham, Kathryn, Jefferies, Sarah, Fresco, Lydia, Sivabalasingham, Suganya, Balfour, Alistair and Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355 2021. Medullary thyroid cancer patient’s assessment of quality of life tools: results from the QaLM study. European Thyroid Journal 10 (1) , pp. 72-78. 10.1159/000509227

Willenbrock, Frances, Cox, Catrin M., Parkes, Eileen E., Wilhelm-Benartzi, Charlotte S. ORCID: https://orcid.org/0000-0003-4927-6158, Abraham, Aswin G., Owens, Robert, Sabbagh, Ahmad, Jones, Christopher M., Hughes, Daniel L. I., Maughan, Tim, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, O'Neill, Eric E. and Mukherjee, Somnath 2021. Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer. British Journal of Cancer 124 , pp. 581-586. 10.1038/s41416-020-01120-z

Jayson, G., Carucci, Margherita, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Zhou, Cong, Monaghan, Phillip, Wych, Julie, Irving, Alys, Narasimham, Monica, Morrison, Hilary, Campbell, Sue, Glasspool, Rosalind, Longo, Mirella ORCID: https://orcid.org/0000-0002-9867-3806, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Dive, Caroline, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243 and Clamp, Andrew 2021. VALTIVE1: Validation of Tie2 as a response biomarker for VEGF inhibitors In Ovarian Cancer. Presented at: NCRI Cancer Conference, 2021.

Owens, R., Cox, C., Gomberg, S., Pan, S., Radhakrishna, G., Parikh, S., Goody, R., Hingorani, M., Prince, S., Bird, T., Dorey, N., Macgregor, U., Al-Chamali, H., Hurt, C. ORCID: https://orcid.org/0000-0003-1206-8355 and Mukherjee, S. 2020. Outcome of weekly carboplatin-paclitaxel-based definitive chemoradiation in oesophageal cancer in patients not considered to be suitable for platinum-fluoropyrimidine-based treatment: a multicentre, retrospective review. Clinical Oncology 32 (2) , pp. 121-130. 10.1016/j.clon.2019.09.058

Piazzese, Concetta ORCID: https://orcid.org/0000-0002-3605-1809, Foley, Kieran, Whybra, Philip, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Crosby, Tom and Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813 2019. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer. PLoS ONE 14 (11) , e0225550. 10.1371/journal.pone.0225550

Hargreaves, Sarah, Beasley, Matthew, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Jones, Terry M. and Evans, Mererid 2019. Deintensification of adjuvant treatment after transoral surgery in patients with human papillomavirus-positive oropharyngeal cancer: The conception of the PATHOS study and its development. Frontiers in Oncology 9 , 936. 10.3389/fonc.2019.00936

Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Ramaraj, Rajeswari, Farr, Angela, Morgan, Meleri, Williams, Namor, Phillips, Ceri J., Williams, Geraint T., Gardner, Georgina, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Sampson, Julian ORCID: https://orcid.org/0000-0002-2902-2348, Hillier, Sharon, Heard, Hayley, Dolwani, Sunil ORCID: https://orcid.org/0000-0002-3113-5472 and CONSCOP Clinical Research Consortium 2019. Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial. Lancet Gastroenterology and Hepatology 4 (5) , pp. 364-375. 10.1016/S2468-1253(19)30035-4

Strauss, Victoria Y., Shaw, Rachel, Virdee, Pradeep S., Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Ward, Elizabeth, Tranter, Bethan, Patel, Neel, Bridgewater, John, Parsons, Philip, Radhakrishna, Ganesh, O'Neill, Eric, Sebag-Montefiore, David, Hawkins, Maria, Corrie, Pippa G., Maughan, Timothy and Mukherjee, Somnath 2019. Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC Cancer 19 (1) , 121. 10.1186/s12885-019-5307-z

Gollins, Simon, West, Nicholas, Sebag-Montefiore, David, Susnerwala, Shabbir, Falk, Stephen, Brown, Nick, Saunders, Mark, Quirke, Philip, Ray, Ruby, Parsons, Philip, Griffiths, Gareth, Maughan, Tim, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243 and Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355 2018. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer 10.1038/s41416-018-0209-4

Prout, Hayley C. ORCID: https://orcid.org/0000-0003-0170-7027, Barham, Allan, Bongard, Emily, Tudor-Edwards, Rhiannon, Griffiths, Gareth, Hamilton, Willie, Harrop, Emily ORCID: https://orcid.org/0000-0003-2820-0023, Hood, Kerry ORCID: https://orcid.org/0000-0002-5268-8631, Hurt, Chris N. ORCID: https://orcid.org/0000-0003-1206-8355, Nelson, Rosie ORCID: https://orcid.org/0000-0002-6075-8425, Porter, Catherine ORCID: https://orcid.org/0000-0003-1851-0677, Roberts, Kirsty, Rogers, Trevor, Thomas-Jones, Emma ORCID: https://orcid.org/0000-0001-7716-2786, Tod, Angela, Yeo, Seow Tien, Neal, Richard D. and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 2018. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials 19 , 419. 10.1186/s13063-018-2803-4

Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Jones, Sadie E. F., Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Fiander, Alison, Nordin, Andrew J., Naik, Raj, Powell, Ned, Carucci, Margherita and Tristram, Amanda 2018. Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multi-centre, randomised, phase II trial (RT3VIN). BJOG: An International Journal of Obstetrics and Gynaecology 125 (9) , pp. 1171-1177. 10.1111/1471-0528.15124

Holyoake, D.L.P., Warren, D.R., Hurt, Chris N. ORCID: https://orcid.org/0000-0003-1206-8355, Aznar, M., Partridge, M., Mukherjee, S. and Hawkins, M.A. 2018. Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer. Clinical Oncology 30 (7) , pp. 418-426. 10.1016/j.clon.2018.02.067

Alderdice, Matthew, Richman, Susan D, Gollins, Simon, Stewart, Peter, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, McCorry, Amy, Roddy, Aideen, Vimalachandran, Dale, Isella, Claudio, Medico, Enzo, Maughan, Tim, McArt, Darragh G, Lawler, Mark and Dunne, Philip D 2018. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies. The Journal of Pathology 245 (1) , pp. 19-28. 10.1002/path.5051

Warren, Samantha, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Crosby, Thomas, Partridge, Mike and Hawkins, Maria A. 2017. Potential of proton therapy to reduce acute hematologic toxicity in concurrent chemoradiation therapy for esophageal cancer. International Journal of Radiation Oncology - Biology - Physics 99 (3) , pp. 729-737. 10.1016/j.ijrobp.2017.07.025

Holyoake, D. L., Partridge, M., Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, S. and Hawkins, M. A. 2017. Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy. International Journal of Radiation Oncology - Biology - Physics 99 (2) , E155. 10.1016/j.ijrobp.2017.06.971

Cox, Samantha, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Grenader, Tal, Mukherjee, Somnath, Bridgewater, John and Crosby, Thomas 2017. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy. Radiotherapy and Oncology 125 (1) , pp. 154-159. 10.1016/j.radonc.2017.08.023

Jones, Sadie E. F., Hibbitts, Samantha, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Bryant, Dean, Fiander, Alison N., Powell, Ned and Tristram, Amanda J. 2017. Human Papillomavirus DNA methylation predicts response to treatment using cidofovir and imiquimod in Vulval Intraepithelial Neoplasia 3. Clinical Cancer Research 23 (18) , pp. 5460-5468. 10.1158/1078-0432.CCR-17-0040

Mukherjee, Somnath, Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 and Crosby, Tom 2017. Response to: Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen. European Journal of Cancer 83 , pp. 333-334. 10.1016/j.ejca.2017.06.040

Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Falk, S., Crosby, T., McDonald, A., Ray, R., Joseph, G., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, R. A., Griffiths, G., Maughan, T. and Mukherjee, S. 2017. Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer. British Journal of Cancer 116 (10) , pp. 1264-1270. 10.1038/bjc.2017.95

Crosby, Tom, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Falk, S, Gollins, S, Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bridgewater, J A, Geh, J I, Cunningham, D, Blazeby, J, Roy, R, Maughan, Timothy, Griffiths, Gwyn and Mukherjee, Saptarshi 2017. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/? cetuximab in oesophageal cancer. British Journal of Cancer 116 (6) , pp. 709-716. 10.1038/bjc.2017.21

Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Farewell, Daniel ORCID: https://orcid.org/0000-0002-8871-1653, Barrett-Lee, Peter, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hawthorne, Anthony Barney, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631 2017. The use of randomisation-based efficacy estimators in non-inferiority trials. Trials 18 (1) , 117. 10.1186/s13063-017-1837-3

Mukherjee, Somnath, Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gwynne, Sarah, Sebag-Montefiore, David, Radhakrishna, Ganesh, Gollins, Simon, Hawkins, Maria, Grabsch, Heike I., Jones, Gareth, Falk, Stephen, Sharma, Ricky, Bateman, Andrew, Roy, Rajarshi, Ray, Ruby, Canham, Jo ORCID: https://orcid.org/0000-0003-3482-0990, Griffiths, Gareth, Maughan, Tim and Crosby, Tom 2017. NEOSCOPE: a randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer 74 , pp. 38-46. 10.1016/j.ejca.2016.11.031

Neal, Richard D., Barham, Allan, Bongard, Emily, Tudor Edwards, Rhiannon, Fitzgibbon, Jim, Griffiths, Gareth, Hamilton, Willie, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Parker, David, Porter, Cath ORCID: https://orcid.org/0000-0003-1851-0677, Prout, Hayley ORCID: https://orcid.org/0000-0003-0170-7027, Roberts, Kirsty, Rogers, Trevor, Thomas-Jones, Emma, Tod, Angela, Yeo, Seow Tien and Hurt, Chris N. ORCID: https://orcid.org/0000-0003-1206-8355 2017. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer 116 (3) , pp. 293-302. 10.1038/bjc.2016.414

Fokas, Emmanouil, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Patel, Neel, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Chu, Kwun-Ye, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross and Mukherjee, Somnath 2016. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: analysis of the on-trial cases for the SCALOP trial. Radiotherapy and Oncology 120 (2) , pp. 212-216. 10.1016/j.radonc.2016.07.002

Cox, S., Powell, C., Carter, Ben Richard, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, Somnath and Crosby, Thomas 2016. Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. British Journal of Cancer 2016 (115) , pp. 172-177. 10.1038/bjc.2016.129

Fokas, E., Spezi, E. ORCID: https://orcid.org/0000-0002-1452-8813, Patel, N., Hurt, C. ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, L. ORCID: https://orcid.org/0000-0002-1270-6970, Chu, K., Joseph, G., Staffurth, J. ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, R. and Mukherjee, S. 2016. P-222 Analysis of tumour contours and radiotherapy planning of 'on-trial' patients undergoing chemoradiotherapy (CRT) in SCALOP trial: does pre-trial Radiotherapy Quality Assurance (RTQA) improve the quality of 'on-trial' radiotherapy? Annals of Oncology 27 (sup. 2) , ii64.3-ii65. 10.1093/annonc/mdw199.214

O'Leary, Maureen, Thomas, Sara, Hurt, Lisa ORCID: https://orcid.org/0000-0002-2741-5383, Floyd, Sian, Shannon, Caitlin, Newton, Sam, Thomas, Gyan, Amenga-Etego, Seeba, Tawiah-Agyemang, Charlotte, Gram, Lu, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Bahl, Rajiv, Owusu-Agyei, Seth, Kirkwood, Betty and Edmond, Karen 2016. Vaccination timing of low-birth-weight infants in rural Ghana: a population-based, prospective cohort study. Bulletin of the World Health Organization 94 (6) , 442-451D. 10.2471/BLT.15.159699

Warren, Samantha, Partridge, Mike, Bolsi, Alessandra, Lomax, Anthony J., Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Crosby, Thomas and Hawkins, Maria A. 2016. An analysis of plan robustness for esophageal tumors: comparing volumetric modulated arc therapy plans and spot scanning proton planning. International Journal of Radiation Oncology - Biology - Physics 95 (1) , pp. 199-207. 10.1016/j.ijrobp.2016.01.044

Carrington, Rhys, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Gwynne, Sarah, Dutton, Peter, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 and Crosby, Thomas 2016. The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial. Radiation Oncology 11 , 19. 10.1186/s13014-016-0594-x

Carrington, R., Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Gwynne, S., Dutton, P., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 and Crosby, T. 2016. The influence of radiotherapy treatment method on dose distribution and its relation to patient outcome in the SCOPE 1 oesophageal cancer trial using Type B algorithms. Radiation Oncology (London, England) 11 , 19. 10.1186/s13014-016-0594-x

Mukherjee, Somnath, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Radhakrishna, Ganesh, Canham, Jo, Ray, Ruby, Grabsch, Heike I., Sharma, Ricky A., Maggs, Rhydian, Hawkins, Maria A., Sebag-Montefiore, David, Maughan, Tim, Griffiths, Gareth and Crosby, Tom David Lewis 2016. NEOSCOPE: a randomised phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma. Journal of Clinical Oncology 34 (4_supp) 10.1200/jco.2016.34.4_suppl.3

Fokas, Emmanouil, Clifford, Charlotte, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Joseph, George, Branagan, Jennifer, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Abrams, Ross, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 and Mukherjee, Somnath 2015. Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial. Radiotherapy and Oncology 117 (3) , pp. 432-437. 10.1016/j.radonc.2015.08.026

Carrington, Rhys, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Warren, Samantha, Partridge, Mike, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Gwynne, Sarah, Hawkins, Maria A. and Crosby, Thomas 2015. The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation. Radiation Oncology 10 , 236. 10.1186/s13014-015-0537-y

Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Farewell, Daniel ORCID: https://orcid.org/0000-0002-8871-1653, Hawthorne, Antony, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter ORCID: https://orcid.org/0000-0002-6246-7357, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Murray, Nick 2015. The use of randomisation-based efficacy estimators in non-inferiority trials [Poster Presentation]. Trials 16 (Suppl) , P129. 10.1186/1745-6215-16-S2-P129

Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, Somnath, Bridgewater, John, Falk, Stephen, Crosby, Tom, McDonald, Alec, Joseph, George, Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross A., Blazeby, Jane M., Bridges, Sarah, Dutton, Peter, Griffiths, Gareth, Maughan, Tim and Johnson, Colin 2015. Health-related quality of life in SCALOP, a randomized phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics 93 (4) , pp. 810-818. 10.1016/j.ijrobp.2015.08.026

Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, Somnath, Bridgewater, John, Falk, Stephen, Crosby, Tom, McDonald, Alec, Joseph, George, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross A., Blazeby, Jane M., Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Dutton, Peter, Griffiths, Gareth, Maughan, Timothy and Johnson, Colin 2015. Health-related quality of life in SCALOP, a randomized Phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer. International Journal of Radiation Oncology Biology Physics 93 (4) , pp. 810-818.

Owadally, Waheeda, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Timmins, Hayley, Parsons, Emma, Townsend, Sarah, Patterson, Joanne, Hutcheson, Katherine, Powell, Ned, Beasley, Matthew, Palaniappan, Nachi, Robinson, Max, Jones, Terence M. and Evans, Mererid 2015. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer 15 , 602. 10.1186/s12885-015-1598-x

Rees, J., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gollins, S., Mukherjee, S., Maughan, Timothy, Falk, S. J., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bashir Mohamad, Nurul, Geh, J. I., Cunningham, D., Roy, R., Bridgewater, J., Griffiths, G., Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Blazeby, J. M. and Crosby, T. 2015. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer 113 (4) , pp. 603-610. 10.1038/bjc.2015.258

Gollins, Simon, Sebag-Montefiore, David, Adams, Richard, Saunders, Mark P., Grieve, Robert, Scott, Nigel, Brown, Gina, Quirke, Philip, Butlin, Laura ORCID: https://orcid.org/0000-0003-2753-1883, Ray, Ruby, Griffiths, Gareth and Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 2015. A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). Journal of Clinical Oncology 33 (15) , p. 3609.

Mukherjee, Somnath, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Radhakrishna, Ganesh, Hawkins, Maria, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Lewis, Wyn, Grabsch, Heike I, Sharma, Ricky A, Wade, Wendy, Maggs, Rhydian, Tranter, Bethan, Roberts, Ashley, Sebag-Montefiore, David, Maughan, Timothy, Griffiths, Gareth and Crosby, Tom 2015. NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer 15 (1) , 48. 10.1186/s12885-015-1062-y

Tristram, Amanda, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Madden, Tracie ORCID: https://orcid.org/0000-0001-7880-7873, Powell, Ned, Man, Stephen ORCID: https://orcid.org/0000-0001-9103-1686, Hibbitts, Sam, Dutton, Peter, Jones, Sadie, Nordin, Andrew J., Naik, Raj, Fiander, Alison and Griffiths, Gareth 2014. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncology 15 (12) , pp. 1361-1368. 10.1016/S1470-2045(14)70456-5

Adamson, Douglas, Blazeby, Jane, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Fitzgibbon, Jim, Crosby, Tom, Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172, Evans, Mim, Hopewell Kelly, Noreen, Cohen, David, Griffiths, Gareth and Byrne, Anthony 2014. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial. Trials 15 , 402. 10.1186/1745-6215-15-402

Warren, Samantha, Partridge, Mike, Carrington, Rhys, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Crosby, Thomas and Hawkins, Maria A. 2014. Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics 90 (2) , pp. 423-429. 10.1016/j.ijrobp.2014.06.028

Mukherjee, Somnath, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Dutton, Peter, Bridgewater, John A., Crosby, Thomas, Mcdonald, Alec, Falk, Stephen, Abrams, Ross A., Maughan, Timothy Stanley and Griffiths, Gareth 2014. Impact of gemcitabine (Gem)-or capecitabine (Cape)-based chemoradiation (CRT) on health-relatedquality of life (HRQL) in patients with locally advanced pancreatic cancer (LAPC): Outcomes from the randomized phase II SCALOP trial [Abstract]. Journal of Clinical Oncology 32 (5) , 4126. 10.1200/jco.2014.32.15_suppl.4126

Crosby, Thomas, Mukherjee, Somnath, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gwynne, Sarah, Gollins, Simon, Batrman, Andrew Rea, Lewis, Wyn Griffith, Radhakrishna, Ganesh, Hawkins, Maria, Grabsch, Heike I., Ray, Ruby, Sharma, Ricky A., Wade, Wendy, Maggs, Rhydian, Tranter, Bethan, Roberts, Ashley, Hadlow, Sue, Sebag-Montefiore, David, Maughan, Tim and Griffiths, Gareth 2014. NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer [Abstract]. Journal of Clinical Oncology 32 (15_sup) , TPS4144. 10.1200/jco.2014.32.15_suppl.tps4144

Huggett, Matthew T., Passant, Helen, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Pereira, Stephen P., Bridgewater, John and Mukherjee, Somnath 2014. Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United Kingdom. Tumori 100 (2) , pp. 219-224. 10.1700/1491.16421

Neal, R. D., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Roberts, K., Rogers, T., Hamilton, W., Tudor Edwards, R., Tod, A. M., Parker, D., Thomas Jones, E., Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Prout, H., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631 and Griffiths, G. 2014. A feasibility randomised controlled trial looking at the effect on lung cancer diagnosis of giving a chest X-ray to smokers aged over 60 with new chest symptoms – the ELCID trial [Abstract]. Lung Cancer 83 , S81-S82. 10.1016/S0169-5002(14)70220-X

Prout, Hayley ORCID: https://orcid.org/0000-0003-0170-7027, Neal, Richard, Roberts, Kirsty, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Rogers, Trevor, Hamilton, Willie, Edwards, Rhiannon, Todd, Angela, Parker, David, Jones, Emma, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Griffiths, Gareth, Barham, Allan, Fitzgibbon, Jim and Nelson, Annmarie 2013. ELCID: early lung cancer identification and diagnosis - an embedded interview study to explore patient participation and recruitment. Trials 14 (S1) , P102. 10.1186/1745-6215-14-S1-P102

Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Mukherjee, S., Wills, L., Millin, T., Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Abrams, R. A., Joseph, G., Griffiths, G., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 and Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 2013. The SCALOP Trial Plan Assessment Form (PAF) as a tool for Radiation Therapy Trials Quality Assurance (RTTQA). International Journal of Radiation Oncology*Biology*Physics 87 (2) , S306. 10.1016/j.ijrobp.2013.06.804

Crosby, Thomas David Lewis, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bashir, Nadim, Bridgewater, John A., Geh, J. Ian, Cunningham, David, Blazeby, Jane, Roy, Rajarshi, Maughan, Timothy Stanley and Griffiths, Gareth O. 2013. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology 14 (7) , pp. 627-637. 10.1016/S1470-2045(13)70136-0

Mukherjee, Somnath, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Bridgewater, John, Falk, Stephen, Cummins, Sebastian, Wasan, Harpreet, Crosby, Thomas David Lewis, Jephcott, Catherine, Roy, Rajarshi, Radhakrishna, Ganesh, McDonald, Alec, Ray, Ruby, Joseph, George, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross A., Griffiths, Gareth O. and Maughan, Timothy Stanley 2013. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. The Lancet Oncology 14 (4) , pp. 317-326. 10.1016/S1470-2045(13)70021-4

Danso, S., Atwell, E., Johnson, O., ten Asbroek, G., Soremekun, S., Edmond, K., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Hurt, Lisa ORCID: https://orcid.org/0000-0002-2741-5383, Zandoh, C., Tawiah, C., Hill, Z., Fenty, J., Amenga Etego, S., Owusu Agyei, S. and Kirkwood, B. R. 2013. A semantically annotated corpus for automatic verbal autopsy analysis. International Computer Archive Of Modern English 37 , pp. 67-100.

Branagan, J. M. R., Halle, C., Falk, S., Radhakrishna, G., Roy, R., Crosby, T., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Brunner, T. B. and Mukherjee, S. 2013. Reduction of interobserver variability (IOV) by FDG-PET-based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer. Journal of Clinical Oncology 31 (4)

Crosby, T., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Falk, S., Gollins, S., Mukherjee, Saptarshi, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bashir, N., Bridgwater, J., Geh, J. I., Cunningham, D., Blazeby, J., Roy, R., Maughan, T and Griffiths, Gareth 2013. SCOPE 1: A phase II/III trial of chemoradiotherapy in esophageal cancer plus or minus cetuximab. American Journal of Clinical Oncology 31 (Supp 4) , LBA3. 10.1200/jco.2013.31.4_suppl.lba3

Mukherjee, Somnath, Halle, Charlotte, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Joseph, George, Mary, Jennifer, Branagan, Rose, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Falk, Stephen, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Abrams, Ross A. and Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 2013. Comparison of investigator-delineated GTV in chemoradiotherapy (CRT) for locally advanced nonmetastatic pancreatic cancer (LANPC): Analysis of the pretrial test case for the SCALOP trial. Journal of Clinical Oncology 31 (4) , 230.

Mukherjee, S., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Griffiths, G., Bridgewater, J. A., Crosby, T., Falk, S., Cummins, S., Roy, R., Mangar, S., Mcdonald, A., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, R. A. and Maughan, T. 2013. SCALOP: Results of a randomized phase II study of induction chemotherapy followed by genicitabine (G) or capecitabine (Cap) based chentoradialion (CRT) in locally advanced pancreatic cancer (LANPC). American Journal of Clinical Oncology 31 (Supp 4)

Hurt, Lisa ORCID: https://orcid.org/0000-0002-2741-5383, ten Asbroek, Augustinus, Amenga-Etego, Seeba, Zandoh, Charles, Danso, Samuel, Edmond, Karen, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Tawiah, Charlotte, Hill, Zelee, Fenty, Justin, Owusu-Agyei, Seth, Campbell, Oona M. and Kirkwood, Betty R. 2013. Effect of vitamin A supplementation on cause-specific mortality in women of reproductive age in Ghana: a secondary analysis from the ObaapaVitA trial. Bulletin of the World Health Organization 91 (1) , pp. 19-27. 10.2471/BLT.11.100412

Crosby, Thomas, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John, Ray, Ruby, Bridgewater, John A., Geh, Ian, Cunningham, David, Maughan, Tim and Griffiths, Gareth 2013. SCOPE 1: a phase II/III trial of chemoradiotherapy in esophageal cancer plus or minus cetuximab. Journal of Clinical Oncology 31 (4_supp) , LBA3. 10.1200/jco.2013.31.4_suppl.lba3

Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Roberts, Kirsty, Rogers, Trevor K, Griffiths, Gareth O., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Prout, Hayley Christine ORCID: https://orcid.org/0000-0003-0170-7027, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Fitzgibbon, Jim, Barham, Allan, Thomas-Jones, Emma, Edwards, Rhiannon, Yeo, Seow, Hamilton, William, Tod, Angela and Neal, Richard D 2013. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials 14 (1) , 405. 10.1186/1745-6215-14-405

Gwynne, Sarah Helene, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Wills, Lucy, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Joseph, George, Evans, Mererid, Griffiths, Gareth O., Crosby, Thomas David Lewis and Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 2012. Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. International Journal of Radiation Oncology*Biology*Physics 84 (4) , pp. 1037-1042. 10.1016/j.ijrobp.2012.01.094

Hendry, Maggie ORCID: https://orcid.org/0000-0002-6436-7771, Pasterfield, Diana, Lewis, Robert, Clements, A., Damery, S., Neal, Richard D., Adke, R., Weller, D., Campbell, C., Patnick, J., Sasieni, P., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Wilson, S. and Wilkinson, Clare Elizabeth 2012. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing. British Journal of Cancer 107 (2) , pp. 243-254. 10.1038/bjc.2012.256

Edmond, Karen, Hurt, Lisa ORCID: https://orcid.org/0000-0002-2741-5383, Fenty, Justin, Amenga-Etego, Seeba, Zandoh, Charles, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Danso, Samuel, Tawiah, Charlotte, Hill, Zelee, ten Asbroek, Augustinus H. A., Owusu-Agyei, Seth, Campbell, Oona and Kirkwood, Betty R. 2012. Effect of vitamin A supplementation in women of reproductive age on cause-specific early and late infant mortality in rural Ghana: ObaapaVitA double-blind, cluster-randomised, placebo-controlled trial. British Medical Journal Open 2 (1) , e000658. 10.1136/bmjopen-2011-000658

Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Griffiths, Gareth O., Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N., Phillips, Ceri J., Blazeby, Jane M. and Crosby, Tom D. 2011. SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer 11 (1) , p. 466. 10.1186/1471-2407-11-466

Gwynne, S., Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Palaniappan, N., Wills, L., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Evans, M., Griffiths, G. and Crosby, T. 2011. Inter-observer variation in outlining of pre-trial test case in the SCOPE1 trial: A United Kingdom definitive chemoradiotherapy trial for esophageal cancer. International Journal of Radiation Oncology - Biology - Physics 81 (2) , S67-S68. 10.1016/j.ijrobp.2011.06.135

Gwynne, Sarah Helene, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Evans, M., Holden, C., Vout, Lauren and Crosby, Thomas David Lewis 2011. Definitive Chemoradiation for Oesophageal Cancer - A Standard of Care in Patients with Non-metastatic Oesophageal Cancer. Clinical Oncology 23 (3) , pp. 182-188. 10.1016/j.clon.2010.12.001

Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 and SEARCH Collaborative Group 2010. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. The Lancet 376 (9753) , pp. 1658-1669. 10.1016/S0140-6736(10)60310-8

Hudson, E., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Mort, D., Brewster, A. E., Iqbal, N., Joseph, George, Crosby, Thomas David Lewis and Mukherjee, Saptarshi 2010. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment. Clinical Oncology 22 (1) , pp. 27-35. 10.1016/j.clon.2009.09.024

Mukherjee, S., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Griffiths, G., Crosby, T. S., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Bridgewater, J. A., Mcdonald, A., Falk, S. and Maughan, Timothy Stanley 2010. A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer. American Journal of Clinical Oncology 28

Kirkwood, Betty R., Hurt, Lisa, Amenga-Etego, Seeba, Tawiah, Charlotte, Zandoh, Charles, Danso, Samuel, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Edmond, Karen, Hill, Zelee, Ten Asbroek, Guus, Fenty, Justin, Owusu-Agyei, Seth, Campbell, Oona and Arthur, Paul 2010. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVita): A cluster-randomized, placebo-controlled trial. Obstetrical & Gynecological Survey 65 (9) , pp. 552-554. 10.1097/OGX.0b013e3182021d40

Kirkwood, Betty R., Hurt, Lisa ORCID: https://orcid.org/0000-0002-2741-5383, Amenga-Etego, Seeba, Tawiah, Charlotte, Zandoh, Charles, Danso, Samuel, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Edmond, Karen, Hill, Zelee, ten Asbroek, Guus, Fenty, Justin, Owusu-Agyei, Seth, Campbell, Oona and Arthur, Paul 2010. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. The Lancet 375 (9726) , pp. 1640-1649. 10.1016/S0140-6736(10)60311-X

Gwynne, Sarah, Wills, Lauren, Joseph, Giannina, John, G., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 and Mukherjee, Saptarshi 2009. Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer1. Clinical Oncology 21 (9) , pp. 713-719. 10.1016/j.clon.2009.07.015

Edmond, Karen M., Quigley, Maria A., Zandoh, Charles, Danso, Samuel, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Agyei, Seth Owusu and Kirkwood, Betty R. 2008. Diagnostic accuracy of verbal autopsies in ascertaining the causes of stillbirths and neonatal deaths in rural Ghana. Paediatric and Perinatal Epidemiology 22 (5) , pp. 417-429. 10.1111/j.1365-3016.2008.00962.x

Edmond, Karen M., Quigley, Maria A., Zandoh, Charles, Danso, Samuel, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Agyei, Seth Owusu and Kirkwood, Betty R. 2008. Aetiology of stillbirths and neonatal deaths in rural Ghana: implications for health programming in developing countries. Paediatric and Perinatal Epidemiology 22 (5) , pp. 430-437. 10.1111/j.1365-3016.2008.00961.x

Patkar, V, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Steele, R, Love, S, Purushotham, A, Williams, M, Thomson, R and Fox, J 2006. Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer. British Journal of Cancer 95 (11) , pp. 1490-1469. 10.1038/sj.bjc.6603470

Bury, Jonathan, Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Roy, Anindita, Cheesman, Louise, Bradburn, Mike, Cross, Simon, Fox, John and Saha, Vaskar 2005. LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia. British Journal of Haematology 129 (6) , pp. 746-754. 10.1111/j.1365-2141.2005.05541.x

Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Fox, J., Bury, J. and Saha, V. 2004. Computerised advice on drug dosage decisions in childhood leukaemia: a method and a safety strategy. Lecture Notes in Computer Science 2780 , pp. 158-162. 10.1007/978-3-540-39907-0_22

Bury, J., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Roy, A., Bradburn, M., Cross, S., Fox, J. and Saha, V. 2004. A quantitative and qualitative evaluation of LISA, a decision support system for chemotherapy dosing in childhood acute lymphoblastic leukaemia. Fieschi, M., Coiera, E. and Yu-Chan, J. L., eds. MEDINFO 2004, Vol. 107. Studies in Health Technology and Informatics, IOS Press, pp. 197-201. (10.3233/978-1-60750-949-3-197)

Fox, J., Alabassi, A., Black, E., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 and Rose, T. 2004. Modelling clinical goals: a corpus of examples and a tentative ontology. Kaiser, Katharina, Miksch, Silvia and Tu, Samson W., eds. Computer-based Support for Clinical Guidelines and Protocols, Vol. 101. Studies in Health Technology and Informatics, IOS Press, pp. 31-45. (10.3233/978-1-60750-944-8-31)

Jarup, L., Briggs, D., de Hoogh, C., Morris, S., Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Lewin, A., Maitland, I., Richardson, S., Wakefield, J. and Elliott, P. 2002. Cancer risks in populations living near landfill sites in Great Britain. British Journal of Cancer 86 (11) , pp. 1732-1736. 10.1038/sj.bjc.6600311

Elliott, P., Briggs, D., Morris, S., de Hoogh, C., Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Jensen, T. K., Maitland, I., Richardson, S., Wakefield, J. and Jarup, L. 2001. Risk of adverse birth outcomes in populations living near landfill sites. British Medical Journal (BMJ) 323 (7309) , pp. 363-368. 10.1136/bmj.323.7309.363

Jarup, L., Briggs, D., deHoogh, C., Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Koid-Jensen, T., Morris, S., Wakefield, J. and Elliott, P. 2001. Health outcomes in populations living close to landfill sites. Epidemiology 12 (4) , S25.

de Hoogh, C., Briggs, D. J., Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Jarup, L. and Elliott, P. 2001. Modelling exposures from landfill sites: Methods and issues. Epidemiology 12 (4) , S42.